LivingGLP1
Study S000994

New Imaging Procedure for the Localisation of Insulinoma

ClinicalTrials.gov record

Registration

Registration
NCT02127541
Study type
INTERVENTIONAL
Masking
SINGLE
Status
COMPLETED
Enrollment
52
Start
2014-01-06
Primary completion
2017-11
Lead sponsor
University Hospital, Basel, Switzerland
Conditions
Endogenous Hyperinsulinaemic Hypoglycaemia
Interventions
OTHER:Ga -exendin PET/CT, In- exendin SPECT/CT, MRI
Results posted
FALSE

Registered primary outcomes

  • Measuring Tumour to Background Ratio [4 years]
  • Measuring the accuracy of the Tumour-Localisation of 68-DOTA-Exendin-4 PET/CT and 111 In-DOTA-exendin-4 SPECT/CT. [4 years]

Linked records (4)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R001883768Ga-Exendin-4 PET/CT Detects Insulinomas in Patients With Endogenous Hyperinsulinemic Hypoglycemia in MEN-1.
Antwi K, The Journal of clinical endocrinology and metabolism
2019OtherPMID 31298706DOIcites ClinicalTrials.gov:NCT02127541; registry reference DERIVED:31298706
R0020232Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
Antwi K, European journal of nuclear medicine and molecular imaging
2018Randomized trialPMID 30054698DOIcites ClinicalTrials.gov:NCT02127541; registry reference DERIVED:30054698
R0021777Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
Christ E, The lancet. Diabetes & endocrinology
2013Other trialPMID 24622317DOIregistry reference BACKGROUND:24622317
R0023243Glucagon-like peptide-1 receptor imaging for localization of insulinomas.
Christ E, The Journal of clinical endocrinology and metabolism
2009Other trialPMID 19820010DOIregistry reference BACKGROUND:19820010